Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 4/2020

25.05.2020 | Original Article

JAK2V617F Mutation in Patient with Splanchnic Vein Thrombosis

verfasst von: Narender Kumar, Saniya Sharma, Jogeshwar Binota, Jasmina Ahluwalia, Neelam Varma, Shano Naseem, Ishwar Chand, Varun Uppal, Saroj K. Sinha

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Splanchnic vein thrombosis is an uncommon life-threatening form of venous thrombosis. It is one the common complication among MPN’s. In the western studies the prevalence of JAK2V617F mutation among SVT patient is high and ranges from 7 to 59%. The frequency of this mutation among Indian SVT patients is heterogenous. This was a prospective case control study. A total 52 cases of SVT and 40 controls were screened for JAK2V617F mutation along with other routine thrombophilic risk factors. Out of total 52 cases, 10 had BCS, 2 had MVT and rest 40 were of PVT/EHPVO. The JAK2V617F mutation was seen in two cases and not in controls. Among the thrombophilic markers, heterozygous FVL mutation, PC, PS and presence of APA were seen in 2, 3, 1 and 3 cases respectively. In addition, eight cases also showed deranged risk factors (5 inherited and 3 acquired), however the repeat testing was not performed due to loss of follow up. Among controls, one person showed presence of APA and one person showed multiple thrombophilic risk factor deficiency. JAK2V617F mutation was observed in 3.8% among north Indian SVT patients. The frequency of mutation is on the lower side as compared to the available Indian data. The other thrombophilia markers (both inherited and acquired) are more frequent (18%) and patients should be routinely screened for these thrombophilia markers.
Literatur
1.
Zurück zum Zitat James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434(7037):1144–1148CrossRef James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 434(7037):1144–1148CrossRef
2.
Zurück zum Zitat Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352(17):1779–1790CrossRef Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 352(17):1779–1790CrossRef
3.
Zurück zum Zitat Falanga A, Marchetti M (2012) Thrombotic disease in the myeloproliferative neoplasms. Hematol Am Soc Hematol Educ Program. 2012:571–581CrossRef Falanga A, Marchetti M (2012) Thrombotic disease in the myeloproliferative neoplasms. Hematol Am Soc Hematol Educ Program. 2012:571–581CrossRef
4.
Zurück zum Zitat Barbui T, Carobbio A, Cervantes F, Vannucchi AM, Guglielmelli P, Antonioli E et al (2010) Thrombosis in primary myelofibrosis: incidence and risk factors. Blood 115(4):778–782CrossRef Barbui T, Carobbio A, Cervantes F, Vannucchi AM, Guglielmelli P, Antonioli E et al (2010) Thrombosis in primary myelofibrosis: incidence and risk factors. Blood 115(4):778–782CrossRef
5.
Zurück zum Zitat Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW (2012) Myeloproliferative neoplasms in Budd–Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood 120(25):4921–4928CrossRef Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW (2012) Myeloproliferative neoplasms in Budd–Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood 120(25):4921–4928CrossRef
6.
Zurück zum Zitat Sekhar M, McVinnie K, Burroughs AK (2013) Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol 162(6):730–747CrossRef Sekhar M, McVinnie K, Burroughs AK (2013) Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol 162(6):730–747CrossRef
7.
Zurück zum Zitat Regina S, Herault O, D’Alteroche L, Binet C, Gruel Y (2007) JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis. J Thromb Haemost 5(4):859–861CrossRef Regina S, Herault O, D’Alteroche L, Binet C, Gruel Y (2007) JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis. J Thromb Haemost 5(4):859–861CrossRef
8.
Zurück zum Zitat Shetty S, Kulkarni B, Pai N, Mukundan P, Kasatkar P, Ghosh K (2010) JAK2 mutations across a spectrum of venous thrombosis cases. Am J Clin Pathol 134(1):82–85CrossRef Shetty S, Kulkarni B, Pai N, Mukundan P, Kasatkar P, Ghosh K (2010) JAK2 mutations across a spectrum of venous thrombosis cases. Am J Clin Pathol 134(1):82–85CrossRef
9.
Zurück zum Zitat Deepak A, Punamiya S, Patel N, Parekh S, Mehta S, Shah N (2011) Prevalence of JAK29V617F mutation in intra-abdominal venous thrombosis. Trop Gastroenterol 32(4):279–284PubMed Deepak A, Punamiya S, Patel N, Parekh S, Mehta S, Shah N (2011) Prevalence of JAK29V617F mutation in intra-abdominal venous thrombosis. Trop Gastroenterol 32(4):279–284PubMed
10.
Zurück zum Zitat Sazawal S, Rathi S, Chikkara S, Chaubey R, Seth T, Saraya A et al (2012) JAK2 mutation in patients with splanchnic venous thrombosis: a pilot study from India. Indian J Med Res 135:429–431PubMedPubMedCentral Sazawal S, Rathi S, Chikkara S, Chaubey R, Seth T, Saraya A et al (2012) JAK2 mutation in patients with splanchnic venous thrombosis: a pilot study from India. Indian J Med Res 135:429–431PubMedPubMedCentral
11.
Zurück zum Zitat Sawant P, Vashishtha C, Nasa M, Parikh P, Patel J, Agasti A (2015) Thrombophilia profile in Budd–Chiari syndrome and splanchnic vein thrombosis: a study from western India. J Assoc Phys India 63(9):32–35 Sawant P, Vashishtha C, Nasa M, Parikh P, Patel J, Agasti A (2015) Thrombophilia profile in Budd–Chiari syndrome and splanchnic vein thrombosis: a study from western India. J Assoc Phys India 63(9):32–35
12.
Zurück zum Zitat Mutreja D, Kotru M, Sazawal S, Ranjan R, Sharma A, Acharya SK et al (2015) Hereditary and acquired thrombophilia in splanchnic vein thrombosis: a single-center experience. Clin Appl Thromb Hemost 21(6):521–526CrossRef Mutreja D, Kotru M, Sazawal S, Ranjan R, Sharma A, Acharya SK et al (2015) Hereditary and acquired thrombophilia in splanchnic vein thrombosis: a single-center experience. Clin Appl Thromb Hemost 21(6):521–526CrossRef
13.
Zurück zum Zitat Rai P, Kumar P, Mishra S, Aggarwal R (2016) Low frequency of V617F mutation in JAK2 gene in Indian patients with hepatic venous outflow obstruction and extrahepatic portal venous obstruction. Indian J Gastroenterol 35(5):366–371CrossRef Rai P, Kumar P, Mishra S, Aggarwal R (2016) Low frequency of V617F mutation in JAK2 gene in Indian patients with hepatic venous outflow obstruction and extrahepatic portal venous obstruction. Indian J Gastroenterol 35(5):366–371CrossRef
14.
Zurück zum Zitat Shukla A, Bhatt P, Gupta DK, Modi T, Patel J, Gupte A et al (2018) Budd–Chiari syndrome has different presentations and disease severity during adolescence. Hepatol Int 12(6):560–566CrossRef Shukla A, Bhatt P, Gupta DK, Modi T, Patel J, Gupte A et al (2018) Budd–Chiari syndrome has different presentations and disease severity during adolescence. Hepatol Int 12(6):560–566CrossRef
15.
Zurück zum Zitat Primignani M, Mannucci PM (2008) The role of thrombophilia in splanchnic vein thrombosis. Semin Liver Dis 28:293–301CrossRef Primignani M, Mannucci PM (2008) The role of thrombophilia in splanchnic vein thrombosis. Semin Liver Dis 28:293–301CrossRef
16.
Zurück zum Zitat De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P et al (2007) Incidence of the JAK2V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 5:708–714CrossRef De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P et al (2007) Incidence of the JAK2V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 5:708–714CrossRef
17.
Zurück zum Zitat Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M et al (2006) Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd–Chiari syndrome. Gastroenterology 130:2031–2038CrossRef Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M et al (2006) Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd–Chiari syndrome. Gastroenterology 130:2031–2038CrossRef
18.
Zurück zum Zitat Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R et al (2006) Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 44:1528–1534CrossRef Primignani M, Barosi G, Bergamaschi G, Gianelli U, Fabris F, Reati R et al (2006) Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology 44:1528–1534CrossRef
19.
Zurück zum Zitat Xavier SG, Gadelha T, Rezende SM, Zalcberg IR, Spector N (2011) JAK2V617F mutation in patients with thrombosis: to screen or not to screen? Int J Lab Hematol 33(2):117–124CrossRef Xavier SG, Gadelha T, Rezende SM, Zalcberg IR, Spector N (2011) JAK2V617F mutation in patients with thrombosis: to screen or not to screen? Int J Lab Hematol 33(2):117–124CrossRef
20.
Zurück zum Zitat Carobbio A, Finazzi G, Antonioli E, Guglielmelli P, Vannucchi AM, Dellacasa CM et al (2009) JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera. Exp Hematol 37(9):1016–1021CrossRef Carobbio A, Finazzi G, Antonioli E, Guglielmelli P, Vannucchi AM, Dellacasa CM et al (2009) JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera. Exp Hematol 37(9):1016–1021CrossRef
21.
Zurück zum Zitat Coucelo M, Caetano G, Sevivas T, Almeida Santos S, Fidalgo T, Bento C et al (2014) JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients. Int J Hematol 99(1):32–40CrossRef Coucelo M, Caetano G, Sevivas T, Almeida Santos S, Fidalgo T, Bento C et al (2014) JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients. Int J Hematol 99(1):32–40CrossRef
22.
Zurück zum Zitat Bertozzi I, Bogoni G, Biagetti G, Duner E, Lombardi AM, Fabris F et al (2017) Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden. Ann Hematol 96(8):1297–1302CrossRef Bertozzi I, Bogoni G, Biagetti G, Duner E, Lombardi AM, Fabris F et al (2017) Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden. Ann Hematol 96(8):1297–1302CrossRef
23.
Zurück zum Zitat Sazawal S, Singh K, Chhikara S, Chaubey R, Mahapatra M, Saxena R (2019) Influence of JAK2V617F allele burden on clinical phenotype of polycythemia vera patients: a study from India. South Asian J Cancer 8(2):127–129PubMedPubMedCentral Sazawal S, Singh K, Chhikara S, Chaubey R, Mahapatra M, Saxena R (2019) Influence of JAK2V617F allele burden on clinical phenotype of polycythemia vera patients: a study from India. South Asian J Cancer 8(2):127–129PubMedPubMedCentral
24.
Zurück zum Zitat Tefferi A, Lasho TL, Schwager SM, Strand JS, Elliott M, Mesa R et al (2006) The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera. Cancer 106:631–635CrossRef Tefferi A, Lasho TL, Schwager SM, Strand JS, Elliott M, Mesa R et al (2006) The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera. Cancer 106:631–635CrossRef
25.
Zurück zum Zitat Vannucchi AM, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R et al (2007) Clinical profile of homozygous JAK2 617 V > F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 110:840–846CrossRef Vannucchi AM, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R et al (2007) Clinical profile of homozygous JAK2 617 V > F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 110:840–846CrossRef
26.
Zurück zum Zitat Pardanani A, Lasho TL, Schwager S, Finke C, Hussein K, Pruthi RK et al (2007) JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder. Leukemia 21(8):1828–1829CrossRef Pardanani A, Lasho TL, Schwager S, Finke C, Hussein K, Pruthi RK et al (2007) JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder. Leukemia 21(8):1828–1829CrossRef
27.
Zurück zum Zitat Goodyer M, Langabeer SE, Haslam K, Murphy K (2016) The JAK2 V617F allele burden in latent myeloproliferative neoplasms presenting with splanchnic vein thrombosis. Pathol Oncol Res 22(1):229–230CrossRef Goodyer M, Langabeer SE, Haslam K, Murphy K (2016) The JAK2 V617F allele burden in latent myeloproliferative neoplasms presenting with splanchnic vein thrombosis. Pathol Oncol Res 22(1):229–230CrossRef
28.
Zurück zum Zitat Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P (2001) Hereditary thrombophilia as a cause of Budd–Chiari syndrome: a study from Western India. Hepatology 34(4):666–670CrossRef Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P (2001) Hereditary thrombophilia as a cause of Budd–Chiari syndrome: a study from Western India. Hepatology 34(4):666–670CrossRef
29.
Zurück zum Zitat Bhattacharyya M, Makharia G, Kannan M, Ahmed RP, Gupta PK, Saxena R (2004) Inherited prothrombotic defects in Budd–Chiari syndrome and portal vein thrombosis: a study from North India. Am J Clin Pathol 121(6):844–847CrossRef Bhattacharyya M, Makharia G, Kannan M, Ahmed RP, Gupta PK, Saxena R (2004) Inherited prothrombotic defects in Budd–Chiari syndrome and portal vein thrombosis: a study from North India. Am J Clin Pathol 121(6):844–847CrossRef
30.
Zurück zum Zitat Ahluwalia J, Naseem S, Sachdeva MU, Bose P, Bose SK, Kumar N et al (2014) Paroxysmal nocturnal hemoglobinuria is rare cause for thrombosis of the intra-abdominal veins in the ethnic Indian population—results from FLAER-based flowcytometry screening. Eur J Haematol 92(5):435–443CrossRef Ahluwalia J, Naseem S, Sachdeva MU, Bose P, Bose SK, Kumar N et al (2014) Paroxysmal nocturnal hemoglobinuria is rare cause for thrombosis of the intra-abdominal veins in the ethnic Indian population—results from FLAER-based flowcytometry screening. Eur J Haematol 92(5):435–443CrossRef
Metadaten
Titel
JAK2V617F Mutation in Patient with Splanchnic Vein Thrombosis
verfasst von
Narender Kumar
Saniya Sharma
Jogeshwar Binota
Jasmina Ahluwalia
Neelam Varma
Shano Naseem
Ishwar Chand
Varun Uppal
Saroj K. Sinha
Publikationsdatum
25.05.2020
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 4/2020
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01292-x

Weitere Artikel der Ausgabe 4/2020

Indian Journal of Hematology and Blood Transfusion 4/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.